Shares of OncoSec Medical Inc. (OTC: ONCS), a company engaged in the design, development and commercialization of novel cancer therapeutic products in the U.S., are up sharply in trading today. At last check, ONCS shares were trading 8.22% higher at $0.262 on above average volume of 2.93 million. The stock hit an intra-day high of $0.28 earlier today. ONCS shares have gained more than 9.50% in the last three trading sessions.
ONCS last month announced the completion of enrollment of Phase II metastatic melanoma trial. Punit Dhillon, President and CEO of OncoSec, said last month that the company is pleased that its development milestones continue to meet expectations.
Shares of Soul and Vice Interactive Inc. (OTC: SOUL), operating as a video and computer games company, have edged higher in trading today. At last check, SOUL shares were trading 1.82% higher at $0.28 on above average volume of 673,982. The stock hit an intra-day high of $0.30 earlier today.
SOUL shares are gaining after the company, on Tuesday, issued a letter to its shareholders. In the letter, the company discussed its publishing & development agreements with Microsoft and Sony. The company also discussed about licensing agreements with globally recognized brands.
Shares of Generex Biotechnology Corporation (OTC: GNBT), a development stage company engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases, are climbing in trading today. At last check, GNBT shares were trading 10.97% higher at $0.0425 on above average volume of 4.81 million. The stock has gained more than 11.80% in the last three trading sessions.
GNBT shares are gaining momentum after the company announced the results of a Phase 3 clinical trial conducted by its Indian licensee, Shreya Life Sciences Pvt. Ltd.
Recent Comments